BONCRESA FDA approval date

The FDA approved BONCRESA on 19 Dec 2025.

FDA approval date
19 Dec 2025

Drug identity has not yet been verified against registry records

Also recorded as DENOSUMAB-MOBZ

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2025-12-19DayBONCRESAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761456", "applicant_as_listed_by_fda": "AMNEAL PHARMS LLC", "brand_names": ["BONCRESA"], "active_ingredients": ["DENOSUMAB-MOBZ"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20251219", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026